AIM IMMUNOTECH INC. (AIM) Operating cash flow 2016–2025
AIM IMMUNOTECH INC. (AIM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$11.0MFY2025 · since FY2016: -$7.4M → -$11.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.0M | +26.4% |
| FY2024 | -$14.9M | +30.0% |
| FY2023 | -$21.3M | -32.0% |
| FY2022 | -$16.1M | -15.3% |
| FY2021 | -$14.0M | -34.7% |
| FY2020 | -$10.4M | -14.3% |
| FY2019 | -$9.1M | +14.8% |
| FY2018 | -$10.6M | -34.0% |
| FY2017 | -$7.9M | -7.6% |
| FY2016 | -$7.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice